Serina Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | -19.3% | -21.6% | +77.8% | +32.0% | -97.3% | +83.6% | +46.9% | +115.6% | -62.4% | |
| – | – | – | – | – | – | -91.4% | +251.6% | +10,280.0% | +46.2% | |
| – | -40.6% | -72.8% | -294.3% | – | – | – | – | -4,193.8% | – | |
| – | -95.7% | +189,200.0% | -66.1% | -96.9% | +442.2% | -91.1% | +5,105.5% | -95.6% | +168.2% | |
| – | – | +26,440.0% | -127.2% | -94.5% | – | +19.1% | -151.4% | -95.6% | +168.2% | |
| – | – | – | – | – | – | – | – | – | +25.0% | |
| – | – | – | – | – | – | – | +668.7% | -71.4% | +70.9% | |
| – | +83.0% | -54.8% | +4.4% | -4.9% | -81.9% | +21.8% | +667.3% | +31.2% | +31.8% | |
| – | – | -109.4% | – | – | – | – | +3,160.1% | -155.7% | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.